MG217 Multi-Symptom Treatment Cream & Skin Protectant recalled over sterility concerns
- Recall date
- April 24, 2026
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Wisconsin Pharmacal Company recalls MG217 Multi-Symptom Treatment Cream & Skin Protectant (colloidal oatmeal 2%), NET WT 6 oz (170 g), Manufactured by: Pha…
- Recall number
- D-0553-2026
- FDA classification
- Class I
- Brand / firm
- Wisconsin Pharmacal Company
- Sold / distributed
- USA Nationwide and Bahamas
Why it was recalled
Microbial Contamination of Non-Sterile Products: confirmed presence of Staphylococcus Aureus.
Class I is the FDA’s most serious recall level: there is a reasonable probability that using this product will cause serious harm or death.
What was recalled
MG217 Multi-Symptom Treatment Cream & Skin Protectant (colloidal oatmeal 2%), NET WT 6 oz (170 g), Manufactured by: Pharmacal 1 Pharmacal Way, P.O. Box 198, Jackson, WI 53037.
Get recall alerts
Free email alert whenever Wisconsin Pharmacal Company has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Wisconsin Pharmacal Company